Skip to main content

Tweets

New download available! Seasonal Flu Vaccination in RA Patients https://t.co/tNwgUVoG7Z https://t.co/P1UqPU57WU
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
IL-17 pathway as a target in giant cell arteritis - full read review of pathogenic role of IL-17 and Th17 cells, in #GCA; backed up by the phase II proof-of-principle TiTAIN study showing potential efficacy of secukinumab in GCA pts https://t.co/MThzw2joGO https://t.co/PmrJjf9C3a
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
2023 EULAR Non-pharmacological Management of Hip and Knee Osteoarthritis: 2023 update EULAR has published the 2023 updated recommendations for the optimal non-pharmacological management of hip and knee osteoarthritis (OA). https://t.co/OjmdAnRWtl https://t.co/gfWYopEgtt
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
Japanese retrospective study compared RA pts on JAK inhib vs bDMARDs (n=62 ea) having orthopedic surgery; JAKi- pts had more postoperative flares (29% v 12%, P=.01), esp if JAKi held >11d (p.04). No diff in other postop complications https://t.co/NVY1Oajdve https://t.co/fwc9KWYZ9l
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
Retrospective cohort compared 6147 new PsA pts vs 23,999 contros PsA. The uveitis risk was significantly higher in PsA (adj HR 2.38). Uveitis risk in PsA higher with prior uveitis (adj OR 136.4) and etanercept Rx (aOR 2.57). 106/107 Rx w/ topical steroids https://t.co/YVzIzSOaiB https://t.co/YORU8cQrAx
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
Increased CV Comorbidity in Dermatomyositis A cohort study suggest that patients with dermatomyositis (DM) are at an increased risk for multiple comorbidities, including chronic kidney and cardiovascular disease, https://t.co/bYvd5AhqSl https://t.co/4y4kjYhTm3
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
Hepatitis B Virus Reactivation is possible w/ immunosuppression- most (>10%) w/ w/ Rituximab & stem cell transplants. If HBsAg positive, pts should recv anti-viral prophylaxis; HBsAg− individuals should be evaluated on a case-by-case basis https://t.co/7JKorgWbYr https://t.co/RdW65u5KDR
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
Metanlysis of 49 studies, 10 RCTs examined the relationship between RA and non-surgical Rx of periodontitis (NSRT) and in general short term studies show that NSPT benefits RA patients; and DMARD therapy benefits periodontitis https://t.co/Bw66VrIMp2 https://t.co/v9SG3sdeni
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
You can still attend RheumNow Live! This 1.5-day long meeting offers pre-learning modules, shorter, concise lectures with clinical context and audience input, more discussion time, and sessions that are relaxed and comprehensive. Register: https://t.co/8jzvDmjVek https://t.co/U10B7zyQdR
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
QD Clinic - RA, SSZ, & MI RA with a myocardial inflarction - which DMARD? https://t.co/FqnouGylMN https://t.co/KzmLctKZBI
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
QD Clinic - GCA & Steroid Weaning Weaning steroids in chronic GCA patient https://t.co/HtrzP43Ivr https://t.co/xZZlNmeqP1
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
CMS Final Rule on Prior Authorization Reforms Prior authorizations and paperwork are killing medical providers; the good news is that a new CMS rule may lessen the burden. https://t.co/bw4Mt06Zgz https://t.co/6B2TXSZuZO
Dr. John Cush @RheumNow ( View Tweet )
2 years 1 month ago
×